Mechanical valve thrombosis in a pregnant woman: A case report

dc.contributor.buuauthorÖzdemir, Bülent
dc.contributor.buuauthorBiçer, Murat
dc.contributor.buuauthorŞentürk, Tunay
dc.contributor.buuauthorBesli, Feyzullah
dc.contributor.buuauthorYeşilbursa, Dilek
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kalp Damar Cerrahisi Anabilim Dalı.tr_TR
dc.contributor.researcheridC-1517-2017tr_TR
dc.contributor.researcheridABC-2231-2020tr_TR
dc.contributor.scopusid7004168959tr_TR
dc.contributor.scopusid6507770944tr_TR
dc.contributor.scopusid8342098300tr_TR
dc.contributor.scopusid35767335000tr_TR
dc.contributor.scopusid36658194500tr_TR
dc.date.accessioned2022-03-17T11:44:53Z
dc.date.available2022-03-17T11:44:53Z
dc.date.issued2009-10
dc.description.abstractWe report a case of metallic prosthetic valve thrombosis in a 24-year-old woman at her 36th week of gestation. With the onset of gestation this patient had been prescribed enoxaparin at a once-daily dose of 0.6 mL, which was lower than the recommended dose. The patient's mitral valve gradient was increased. We gave her intravenous unfractionated heparin because she refused to give consent for thrombolytic therapy owing to its potential hazards for the fetus. After the patient gave birth we treated her with a thrombolytic agent and the thrombus completely dissolved. Pregnancy in patients with mechanical valve prosthesis requires close follow-up and patient adherence to the prescribed medications. In case of thrombus formation both the fetus and the mother are at risk for fatal complications.en_US
dc.identifier.citationÖzdemir, B. vd. (2009). "Mechanical valve thrombosis in a pregnant woman: A case report". Heart Surgery Forum, 12(5), E305-E307.en_US
dc.identifier.endpageE307tr_TR
dc.identifier.issn1098-3511
dc.identifier.issue5tr_TR
dc.identifier.pubmed20077632tr_TR
dc.identifier.scopus2-s2.0-85047686543tr_TR
dc.identifier.startpageE305tr_TR
dc.identifier.urihttps://doi.org/10.1532/HSF98.20081032
dc.identifier.urihttp://hdl.handle.net/11452/25140
dc.identifier.volume12tr_TR
dc.identifier.wos000271489400014tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherForum Multimedia Publishingen_US
dc.relation.journalHeart Surgery Forumen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHeart-valvesen_US
dc.subjectComplicationsen_US
dc.subjectManagementen_US
dc.subjectWomenen_US
dc.subjectCardiovascular system & cardiologyen_US
dc.subjectSurgeryen_US
dc.subject.emtreeEnoxaparinen_US
dc.subject.emtreeFibrinolytic agenten_US
dc.subject.emtreeHeparinen_US
dc.subject.emtreeTissue plasminogen activatoren_US
dc.subject.emtreeWarfarinen_US
dc.subject.emtreeAnticoagulant agenten_US
dc.subject.emtreeFibrinolytic agenten_US
dc.subject.emtreeHeparinen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAnticoagulant therapyen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBirthen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeDrug dose titrationen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFetus risken_US
dc.subject.emtreeFibrinolytic therapyen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeGestational ageen_US
dc.subject.emtreeHeart auscultationen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeInternational normalized ratioen_US
dc.subject.emtreePartial thromboplastin timeen_US
dc.subject.emtreePatient complianceen_US
dc.subject.emtreePregnant womanen_US
dc.subject.emtreePrescriptionen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeProsthetic valve thrombosisen_US
dc.subject.emtreeSystolic heart murmuren_US
dc.subject.emtreeThrombogenesisen_US
dc.subject.emtreeTransesophageal echocardiographyen_US
dc.subject.emtreeDose responseen_US
dc.subject.emtreeEchocardiographyen_US
dc.subject.emtreeHeart valve prosthesisen_US
dc.subject.emtreeMitral valveen_US
dc.subject.emtreeNewbornen_US
dc.subject.emtreePostoperative complicationen_US
dc.subject.emtreePregnancyen_US
dc.subject.emtreePregnancy complicationen_US
dc.subject.emtreePuerperal disorderen_US
dc.subject.emtreeRheumatic feveren_US
dc.subject.emtreeThrombosisen_US
dc.subject.meshAdulten_US
dc.subject.meshAnticoagulantsen_US
dc.subject.meshDose-response relationship, drugen_US
dc.subject.meshEchocardiographyen_US
dc.subject.meshFemaleen_US
dc.subject.meshFibrinolytic agentsen_US
dc.subject.meshHeart valve prosthesisen_US
dc.subject.meshHeparinen_US
dc.subject.meshHumansen_US
dc.subject.meshInfant, newbornen_US
dc.subject.meshMitral valveen_US
dc.subject.meshPartial thromboplastin timeen_US
dc.subject.meshPostoperative complicationsen_US
dc.subject.meshPregnancyen_US
dc.subject.meshPregnancy complications, hematologicen_US
dc.subject.meshPuerperal disordersen_US
dc.subject.meshRheumatic feveren_US
dc.subject.meshThrombosisen_US
dc.subject.meshTissue plasminogen activatoren_US
dc.subject.scopusHeart Valve Prostheses; Mitral Valve; Thrombosisen_US
dc.subject.wosCardiac & cardiovascular systemsen_US
dc.subject.wosSurgeryen_US
dc.titleMechanical valve thrombosis in a pregnant woman: A case reporten_US
dc.typeArticle
dc.wos.quartileQ4en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: